Loading…
Traded May 1, 2026 · Filed May 5, 2026
Newmont's MD, Americas sold $253K of Newmont shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$252,813
Shares × reported transaction price
8 days after results of Apr 23, 2026, 83 days before results of Jul 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $108.62 on May 1, 2026, 123% above its 52-week low and 18% below its high, after a 10% rise over the previous 30 trading days
52-week range $48.66 (May 14, 2025) to $131.95 (Jan 28, 2026), 72% of the way up, from 251 adjusted closes. 30 trading days earlier: $99.20 on Mar 19, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Jan 31, 2025 in the U.S. District Court, D. Colorado. A filing is an allegation, not a finding.
Karas v. Newmont Corporation, docket 1:25-cv-00341, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +9.8% | +2.0% | +7.8% |
| 30 days | -0.6% | +4.6% | -5.2% |
| 90 days | -12.5% | +4.7% | -17.2% |
Past results only. Not a forecast.
Officer sold ~$316K of Newmont
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
